Header cover image
  • Investing Ideas
  • /
  • Pakistani Pharmaceuticals & Biotech Undervalued over 20% based on DCF

Pakistani Pharmaceuticals & Biotech Undervalued over 20% based on DCF

Results

1

0 new

Companies which are undervalued more than 20% based on the Discounted Cash Flow valuation.

1 companies

Highnoon Laboratories

Market Cap: PK₨60.0b

Manufactures, imports, sells, exports, and markets pharmaceutical and allied consumer products.

HINOON

PK₨1,132.16

7D

3.0%

1Y

68.4%